Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

No treatment is clearly better for central serous chorioretinopathy, and more research is needed.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Accidentally eating autumn crocus can cause long-term health issues.

Alkaloids show promise in treating cholangiocarcinoma by effectively targeting cancer cells.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Strontium ranelate is no longer available for treatment.

Avacopan may cause unexpected side effects, so early monitoring is important.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Ovarian steroid cell tumors can mimic adrenal hyperplasia, and surgery can normalize hormone levels.

Finasteride improved reflexes and motor activity in rats with liver-related brain issues.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

A child's scalp infection was caused by a fungus not previously known to do so, but it was successfully treated.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

Cimetidine did not reduce hair growth in women with hirsutism.